DIA
Drug Information Association Logo

Disruptive Innovation in Medical Information

Oct 6 2014 11:00AM - Oct 6 2014 12:30PM | Online

« Back to Listing

Overview 

This webinar will be broadcast in Eastern Time (ET)


Wikipedia describes Disruptive Innovation as “an innovation that helps create a new market and value network, and eventually goes on to disrupt an existing market and value network (over a few years or decades), displacing an earlier technology.” Disruptive innovation can be exhilarating and uncomfortable.

How is disruptive innovation applicable to Medical Information/ Communications? Why should Medical Information/ Communications departments consider disruptive innovation?

This webinar will explore the adoption of disruptive innovation among global medical information/communications departments. Case studies will be shared to provide real world examples of how global disruptive innovation [successes and challenges] is advancing strategic direction and operational efficiencies such as how medical information is being processed, packaged, and communicated to health care professionals.

Who Should Attend 

Professionals involved in:

  • Medical Information
  • Medical Communications
  • Medical Contact/Call Centers
  • Industry, Academia, and Government

Learning Objectives 

At the conclusion of this session, participants should be able to:

  • Recognize disruptive innovation that is being adopted within medical information/communications departments
  • Discuss disruptive innovation trends within the industry
  • Define disruptive innovation strategies used by other pharmaceutical companies to successfully inform future operational models

Contact Information 

Printable Registration Form

Registration Questions and Technical Support Day of Event
Customer Service Department
Toll Free: 1.888.257.6457
Phone: +1.215.442.6100
Fax: +1.215.442.6199
CustomerService@diahome.org

Agenda Details
Carrie Dunn, Content Lead
Phone +1.215.442.6181
Fax +1.215.442.6199
Carrie.Dunn@diahome.org

Event Logistics
Ellen Diegel, Event Planner
Phone +1.215.293.5810
Fax +1.215.442.6199
Ellen.Diegel@diahome.org

Technical Requirements 

Click here for minimum system requirements.

Technical Support Day of Event
Customer Service Department
Phone: +1.888.257.6457 | +1.215.442.6100
CustomerService@diahome.org

Presenter(s) 

Previous Next

Continuing Education 

The Drug Information Association (DIA) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is designated for 1.5 contact hours or .15 continuing education units (CEU’s). 0286-0000-14-090-L04-P; Type of Activity: Application

ACPE Credit Request Update
DIA is required by the Accreditation Council for Pharmacy Education (ACPE) to report pharmacy-requested CEUs through the CPE Monitor system. All ACPE-certified activity credit requests need to be submitted through DIA’s My Transcript within 45-days post activity. Pharmacists will need to provide their National Association of Boards of Pharmacy (NABP) e-Profile ID and date of birth (MMDD) to ensure the data is submitted to the ACPE and NABP properly. If you need to obtain your NABP e-Profile, please visit www.cpemonitor.net.

The DIA has been accredited as an Authorized Provider by the International Association for Continuing Education and Training (IACET).

As an IACET Authorized Provider, DIA offers CEUs for its programs that qualify under the ANSI/IACET Standard. DIA is authorized by IACET to offer .2 CEUs for this program. Participants must attend the entire program in order to be able to receive an IACET statement of credit. No partial credit will be awarded.

Name Credit Type Max Credits CEU
Disruptive Innovation in Medical Information ACPE 1.50 0.150
Disruptive Innovation in Medical Information IACET 1.50 0.200

Disclosure Policy:

It is DIA policy that anyone in a position to control the content of a continuing education activity must disclose to the program audience (1) any real or apparent conflict(s) of interest related to the content of their presentation and/or the educational activity, and (2) discussions of unlabeled or unapproved uses of drugs or medical devices. Disclosure statements will be included in the course materials.

Statement of Credit:

Statement of Credit
If you would like to receive a statement of credit, you must participate in the live webinar, and complete the credit request process through My Transcript. To access My Transcript, please go to www.diahome.org, select “Login to My DIA” and you will be prompted for your user ID and password. Select “My Transcript” (left side bar) and “Credit Request” to process your credit request. Participants will be able to download a statement of credit upon successful submission of the credit request. My Transcript will be available for credit requests on Monday, October 20, 2014.

Continuing education credits are available to learners who participate in the live webinar. Continuing education credits are not available for participation in the archived version of the webinar.

Registration Fees 

Other Fees

Group Site
$799.00
Group Plus
$1499.00

Member

Member Government
$125.00
Charitable Nonprofit/Academia Member
$175.00
Member Individual
$250.00

Non-Member

NonMember Government
$125.00
Charitable Nonprofit/Academia Nonmember
$175.00
NonMember Individual
$350.00
Registration Information

Individual registration is a license for ONE internet login allowing one viewer.
Group site registration is a license for ONE internet login allowing multiple viewers from one location.
Group Plus is a license for up to FIVE internet logins allowing one or more viewers at each login location.


Cancellations:  No refunds will be provided in the event of a participant’s cancellation since all costs for this webinar have been prepaid by DIA. DIA reserves the right to modify or cancel programs and/or substitute presenters or panelists. DIA is not responsible for failure to deliver programs due to circumstances beyond its control.

Participants with Disabilities: Reasonable accommodations will be made available to persons with disabilities who attend an educational activity. Contact the DIA office in writing at least 15 days prior to event to indicate your needs.

Register Online

Unless otherwise disclosed, the statements made by speakers represent their own opinions and not necessarily those of the organization they represent, or that of the Drug Information Association. Speakers, agenda and CE information are subject to change without notice. Recording of any DIA educational material in any type of media is prohibited without prior written consent from DIA.

« Back to Listing Back To Top